Taxol and recombinant human granulocyte colony-stimulating factor, an active regimen as initial therapy for metastatic breast cancer. A preliminary report.
Ann N Y Acad Sci. 1993 Nov 30;698:398-402. doi: 10.1111/j.1749-6632.1993.tb17232.x.
Ann N Y Acad Sci. 1993.
PMID: 7506506
Clinical Trial.
No abstract available.